University of Auckland Partners with Thomson Reuters to Advance Biomedical Research Capabilities
(Thomson Reuters ONE) -
University selects Thomson Reuters Cortellis for Competitive Intelligence to
ensure access to best quality drug development data
PHILADELPHIA, March 11, 2013 - The Intellectual Property & Science business of
Thomson Reuters, the world's leading provider of intelligent information for
businesses and professionals, today announced that the University of Auckland
(UoA), New Zealand, selected Thomson Reuters Cortellis(®) for Competitive
Intelligence to grow the institution's biomedical research program and ensure
future science and business professionals have access to premiere drug
development data.
"Biomedical research is one of UoA's key strengths, as reflected by our high
international rankings, several significant biomedical institutes/centers, and
the university's Biopharma thematic research program", said Professor Joerg
Kistler, director of the Institute for Innovation in Biotechnology, University
of Auckland. "We are focused on ensuring we provide access to leading tools and
resources across the entire value chain for drug research and development, from
bench to bedside. Databases such as Thomson Reuters Cortellis are essential to
developing research programs and funding applications."
The strategic partnership between the University of Auckland and Thomson Reuters
represents the beginning of a trend in medical research, where institutions are
implementing commercial tools for students and researchers, to ensure both have
access to the latest, most critical information for their work. It also ensures
that, as students graduate and enter the workforce, they are well-prepared for
their future roles and have a competitive advantage by being fluent on Thomson
Reuters Cortellis.
"The students of the medical and business schools will benefit greatly from
Thomson Reuters Cortellis as they learn how to work with tools used in the
'outside world,' as well as gain confidence when starting their first jobs,"
said Professor Kistler.
"Thomson Reuters is pleased to set this benchmark milestone with the University
of Auckland," said Jon Brett-Harris, managing director of Life Sciences at
Thomson Reuters. "It is a strong vote of confidence that UoA has selected
Cortellis with a perpetual license for many future generations of scientists and
researchers."
The solution is being used by various institutes and centers at the University
of Auckland, including the School of Medical Sciences, School of Biological
Sciences, School of Chemical Sciences (Medicinal Chemistry), Center for Cancer
Research, Maurice Wilkins Center, Liggins Institute, Institute for Innovation in
Biotechnology and the University Commercialization Office.
Professor Kistler explained the importance of giving so many students and
researchers access to Cortellis: "The value all the centers found in Cortellis
was so high that the University Library decided to support the investment via a
perpetual license. This makes UoA the first university to buy the rights to this
precious data for the benefit of furthering its research and allowing its
community of scientists and students to have the best tools to perform world-
class research."
Thomson Reuters Cortellis for Competitive Intelligence is the premiere platform
for timely and accurate life sciences information, including drug pipeline data,
patents, companies and the latest industry news, providing a full picture of the
competitive landscape in a selected therapy area.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for
businesses and professionals. We combine industry expertise with innovative
technology to deliver critical information to leading decision makers in the
financial and risk, legal, tax and accounting, intellectual property and science
and media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs approximately 60,000 people and operates in over 100
countries. For more information, go to www.thomsonreuters.com.
CONTACT
Jen Breen
jennifer.breen(at)thomsonreuters.com
+1 215 823 1791
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
[HUG#1684158]
Unternehmensinformation / Kurzprofil:
Datum: 11.03.2013 - 22:00 Uhr
Sprache: Deutsch
News-ID 238243
Anzahl Zeichen: 5151
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"University of Auckland Partners with Thomson Reuters to Advance Biomedical Research Capabilities"
steht unter der journalistisch-redaktionellen Verantwortung von
Thomson Reuters Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
